Cargando…
PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies
SIMPLE SUMMARY: PT-112 is a novel pyrophosphate–platinum conjugate under Phase 1/2 clinical development for the treatment of several tumor types. In this study, using mouse tumor cells with well-characterized mitochondrial and metabolic status, we investigated the mechanisms underlying PT-112’s canc...
Autores principales: | Soler-Agesta, Ruth, Marco-Brualla, Joaquín, Minjárez-Sáenz, Martha, Yim, Christina Y., Martínez-Júlvez, Marta, Price, Matthew R., Moreno-Loshuertos, Raquel, Ames, Tyler D., Jimeno, José, Anel, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405950/ https://www.ncbi.nlm.nih.gov/pubmed/36010843 http://dx.doi.org/10.3390/cancers14163851 |
Ejemplares similares
-
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours
por: Karp, Daniel D., et al.
Publicado: (2022) -
A Mutation in Mouse MT-ATP6 Gene Induces Respiration Defects and Opposed Effects on the Cell Tumorigenic Phenotype
por: Moreno-Loshuertos, Raquel, et al.
Publicado: (2023) -
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
por: Yamazaki, Takahiro, et al.
Publicado: (2020) -
Mutations in the ND2 Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
por: Marco-Brualla, Joaquín, et al.
Publicado: (2019) -
Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity
por: Soler-Agesta, Ruth, et al.
Publicado: (2022)